Psychological Interventions for Cannabis Use among Adolescents and Young Adults: A Systematic Review.

Autor: Bou Nassif Y; Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, 92100 Boulogne Billancourt, France.; Consultations en Addictologie pour Adolescent, Centre des Troubles de Neuro-Développement chez l'Adulte, Groupe Hospitalier Universitaire, Site Sainte-Anne, 75014 Paris, France., Rahioui H; Consultations en Addictologie pour Adolescent, Centre des Troubles de Neuro-Développement chez l'Adulte, Groupe Hospitalier Universitaire, Site Sainte-Anne, 75014 Paris, France., Varescon I; Laboratoire de Psychopathologie et Processus de Santé, Université Paris Cité, 92100 Boulogne Billancourt, France.
Jazyk: angličtina
Zdroj: International journal of environmental research and public health [Int J Environ Res Public Health] 2023 Jul 12; Vol. 20 (14). Date of Electronic Publication: 2023 Jul 12.
DOI: 10.3390/ijerph20146346
Abstrakt: Regular cannabis use during adolescence can lead to cognitive, psychological, and social consequences, causing significant distress. Although psychological interventions are the mainstay type of treatment for cannabis use disorder, the results remain mixed among youths. The objective of this review is twofold: to identify the existing psychological interventions for cannabis use among youths, and to assess the evidence regarding the effectiveness of those interventions. Randomized controlled trials focused exclusively on cannabis use among adolescents and young adults were included. Three databases-Embase, PsycInfo, and PubMed-were searched to identify relevant peer-reviewed manuscripts published before February 2022 in English and French. The risk of bias was assessed using the Cochrane Collaboration's tool. Twenty-five randomized controlled trials were included. Fourteen studies reported a significant outcome related to cannabis use. These were mainly non-intensive, online interventions that aimed to improve the patients' relationships and emotion regulation. This review highlights the need to conduct additional randomized control trials that target cannabis use disorder specifically among adolescents. These randomized control trials should also aim to reduce the risk of bias related to psychiatric comorbidities as well as detection and attrition problems.
Databáze: MEDLINE